Moreover, the RRM2 expression levels paralleled the changes of CREB1 in the CRC cases as shown by immunohistochemical analyses (p<0.05) (Figure 5C and Supplementary Table S1). This evidence concerns the gene RRM2 and colorectal carcinoma.